Bonyf N.V. Logo

Bonyf N.V.

Develops patented oral, dental, and dermatological care products for consumers and professionals.

MLBON | BR

Overview

Corporate Details

ISIN(s):
BE6333353298
LEI:
699400NGN0HE0QBIF505
Country:
Belgium
Address:
Doornzelestraat 114 bus D, 9000 Gent
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Bonyf N.V. is a healthcare company specializing in the research, development, production, and marketing of innovative oral, dental, and dermatological care products. The company's portfolio includes a range of dental consumer goods and professional consumables, as well as specialized solutions for denture, orthodontic, and wound care. A leader in dental care innovation, Bonyf focuses on developing clinically validated and patented products, such as its NitrAdine®-based treatments (PerioTabs®, Periocream). The company targets both consumers and dental professionals and is actively expanding its global presence through strategic partnerships in key markets, including the United States and India.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bonyf N.V. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 17:28
Regulatory News Service
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Dusseldorf
English 16.3 KB
2025-09-05 10:51
Share Issue/Capital Change
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developm…
English 15.3 KB
2025-08-11 15:16
Business and Financial Review
Periocream: The Future Commercial Winner for bonyf
English 17.8 KB
2025-07-14 17:43
Regulatory News Service
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
English 21.7 KB
2025-06-30 21:18
Earnings Release
Annual Results 2024
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all Bonyf N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bonyf N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-15 Bogaert Jean-Pierre Executive member Sell 4,900 82,810.00 EUR
2025-05-01 Bogaert Jean-Pierre Executive member Sell 3,782 66,563.20 EUR
2025-03-06 Bogaert Jean-Pierre Executive member Sell 15,000 262,500.00 EUR
2025-02-26 Bogaert Jean-Pierre Executive member Sell 3,128 59,432.00 EUR
2025-02-21 Bogaert Jean-Pierre Executive member Sell 1,986 36,741.00 EUR
2025-02-13 Bogaert Jean-Pierre Executive member Sell 6,030 108,540.00 EUR
2025-02-12 Bogaert Jean-Pierre Executive member Sell 1,300 24,700.00 EUR
2024-12-30 Bogaert Jean-Pierre Executive member Sell 1,400 25,200.00 EUR
2024-12-20 Bogaert Jean-Pierre Executive member Sell 1,250 23,750.00 EUR
2024-12-17 Bogaert Jean-Pierre Executive member Sell 1,700 32,300.00 EUR

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN

Talk to a Data Expert

Have a question? We'll get back to you promptly.